4//SEC Filing
Kumar Ravindra 4
Accession 0001179110-17-012763
CIK 0001280600other
Filed
Sep 28, 8:00 PM ET
Accepted
Sep 29, 4:13 PM ET
Size
6.5 KB
Accession
0001179110-17-012763
Insider Transaction Report
Form 4
Kumar Ravindra
VP & Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2017-09-28$5.28/sh+6,761$35,698→ 96,975 total - Exercise/Conversion
Option to Purchase Common Stock
2017-09-28−6,761→ 0 totalExercise: $5.28Exp: 2022-06-07→ Common Stock (6,761 underlying)
Footnotes (1)
- [F1]The options of registrant's common stock vested in equal quarterly installments over the first four years after the grant.
Documents
Issuer
ACCELERON PHARMA INC
CIK 0001280600
Entity typeother
Related Parties
1- filerCIK 0001586835
Filing Metadata
- Form type
- 4
- Filed
- Sep 28, 8:00 PM ET
- Accepted
- Sep 29, 4:13 PM ET
- Size
- 6.5 KB